Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Debt Ratio (2016)

Gyre Therapeutics (GYRE) has disclosed Debt Ratio for 7 consecutive years, with 0.0 as the latest value for Q3 2016.

  • On a quarterly basis, Debt Ratio fell 94.02% to 0.0 in Q3 2016 year-over-year; TTM through Sep 2016 was 0.0, a 94.02% decrease, with the full-year FY2015 number at 0.02, changed N/A from a year prior.
  • Debt Ratio was 0.0 for Q3 2016 at Gyre Therapeutics, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.02 in Q4 2015 to a low of 0.0 in Q3 2016.
  • A 5-year average of 0.01 and a median of 0.01 in 2013 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: skyrocketed 120.39% in 2015, then crashed 94.02% in 2016.
  • Gyre Therapeutics' Debt Ratio stood at 0.01 in 2012, then dropped by 25.7% to 0.01 in 2013, then plummeted by 47.14% to 0.0 in 2014, then surged by 303.95% to 0.02 in 2015, then plummeted by 96.74% to 0.0 in 2016.
  • Per Business Quant, the three most recent readings for GYRE's Debt Ratio are 0.0 (Q3 2016), 0.0 (Q2 2016), and 0.0 (Q1 2016).